Jennings Courtney L, Lambert Estelle V, Collins Malcolm, Levitt Naomi S, Goedecke Julia H
UCT/MRC Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, PO Box 115, Newlands 7725, South Africa.
Metabolism. 2009 Feb;58(2):149-57. doi: 10.1016/j.metabol.2008.09.007.
The appropriateness of the metabolic syndrome criteria as an indicator of cardiovascular disease risk has been challenged in black Africans. Hence, the aims of this study were (1) to examine the level of agreement between the International Diabetes Federation (IDF) and the National Cholesterol Education Program Adult Treatment Panel III (ATP III) metabolic syndrome criteria, which differ in their emphasis on central obesity; (2) to investigate the degree to which these criteria predict insulin resistance, as estimated by the homeostasis model assessment of insulin resistance (HOMA-IR); and (3) to investigate the extent to which a diagnosis of the metabolic syndrome and insulin resistance may be explained by body fat and its distribution. In 103 normal-weight (body mass index <or=25 kg/m(2), mean: 22.0 +/- 1.8 kg/m(2)) and 119 obese (body mass index >or=30 kg/m(2), mean: 33.9 +/- 5.5 kg/m(2)) urbanized black South African women (27 +/- 7 years old), body composition (dual-energy x-ray absorptiometry), fat distribution (waist and computed tomography), blood pressure, fasting glucose, HOMA-IR, and lipid profiles were measured. Insulin resistance was defined as the upper tertile of HOMA-IR. The overall proportion of individuals who met the IDF and ATP III metabolic syndrome criteria were 13% and 10%, respectively. Agreement was high between the IDF and ATP III metabolic syndrome criteria (kappa = 0.87); however, neither criteria predicted HOMA-IR (kappa = 0.16, 95% confidence interval: 0.05-0.27 and 0.14, 95% confidence interval: 0.05-0.27, respectively). Visceral adipose tissue was the largest contributor to diagnosis of the metabolic syndrome, and waist alone (>80 cm or >88 cm) had an improved specificity (21% or 18% higher, respectively) and positive predictive value (64% or 57% higher, respectively) for identifying insulin resistance compared with the metabolic syndrome criteria. Waist circumference was a better predictor of HOMA-IR than the IDF or ATP III metabolic syndrome criteria in young black African women without known disease. The measurement of waist circumference, as an indicator of disease risk, should therefore be encouraged in the public health setting.
代谢综合征标准作为心血管疾病风险指标在非洲黑人中的适用性受到了质疑。因此,本研究的目的是:(1)检验国际糖尿病联盟(IDF)和美国国家胆固醇教育计划成人治疗组第三次报告(ATP III)代谢综合征标准之间的一致性水平,这两种标准在对中心性肥胖的强调上有所不同;(2)调查这些标准预测胰岛素抵抗的程度,胰岛素抵抗通过胰岛素抵抗稳态模型评估(HOMA-IR)进行估计;(3)调查代谢综合征和胰岛素抵抗的诊断在多大程度上可以由体脂及其分布来解释。对103名体重正常(体重指数≤25kg/m²,平均:22.0±1.8kg/m²)和119名肥胖(体重指数≥30kg/m²,平均:33.9±5.5kg/m²)的城市化南非黑人女性(27±7岁)测量了身体成分(双能X线吸收法)、脂肪分布(腰围和计算机断层扫描)、血压、空腹血糖、HOMA-IR和血脂谱。胰岛素抵抗定义为HOMA-IR的上三分位数。符合IDF和ATP III代谢综合征标准的个体总体比例分别为13%和10%。IDF和ATP III代谢综合征标准之间的一致性较高(kappa=0.87);然而,两种标准均未预测HOMA-IR(kappa分别为0.16,95%置信区间:0.05-0.27和0.14,95%置信区间:0.05-0.27)。内脏脂肪组织是代谢综合征诊断的最大贡献因素,单独的腰围(>80cm或>88cm)与代谢综合征标准相比,在识别胰岛素抵抗方面具有更高的特异性(分别高了21%或18%)和阳性预测值(分别高了64%或57%)。在无已知疾病的年轻非洲黑人女性中,腰围比IDF或ATP III代谢综合征标准是更好的HOMA-IR预测指标。因此,在公共卫生环境中,应鼓励测量腰围作为疾病风险的指标。